ARWR logo
ARWR NASDAQ US

Arrowhead Pharmaceuticals, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 1993
$61.03
▼ $-1.89 (-3.00%)
Vol 1.5M
5
Quality Score
fail
Mkt Cap
$9.0B
ROE
-0.4%
Margin
-0.2%
D/E
133.52
Beta
1.23
52W
$10–$72

Wall Street Consensus

19 analysts · Apr 2026
4
Strong Buy
11
Buy
4
Hold
0
Sell
0
Strong Sell
78.9%
Buy Rating

Price Chart

Similar Stocks

IONS
Ionis Pharmaceuticals Inc
$12.8B
EXEL
Exelixis Inc
P/E 17.3
$11.8B
BMRN
BioMarin Pharmaceutical Inc
P/E 21.9
$11.4B
PRAX
Praxis Precision Medicines Inc
$7.4B
PCVX
Vaxcyte Inc
$6.0B
CYTK
Cytokinetics Inc
$7.8B
NUVL
Nuvalent, Inc
$7.3B
KRYS
Krystal Biotech Inc
P/E 35.9
$7.1B

Earnings

Beat rate: 50.0%
Next Report May 11, 2026
EPS Estimate: $-1.21
Quarter EPS Est EPS Act Surprise
Jun 2026 $-1.21 — —
Dec 2025 $0.26 $0.22 $-0.04
Sep 2025 $-0.25 $-0.18 +$0.07
Jun 2025 $-1.05 $-1.26 $-0.21

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -41.3% -41.1% -41.1% -41.1% -0.4% -0.4%
P/E (TTM) — — — — — —
Net Margin -631.1% 3.9% 3.9% 3.9% -0.2% -0.2%
Gross Margin — — — — — —
D/E Ratio 114.99 46.01 114.99 114.99 133.52 133.52
Current Ratio 4.87 4.87 4.87 4.87 4.86 4.86

Key Ratios

ROA (TTM)
-0.1%
P/S (TTM)
10.87
P/B
10.2
EPS (TTM)
$-0.06
CF/Share
$-1.62
Rev Growth 3Y
+50.5%
52W High
$72.36
52W Low
$9.57
$9.57 52-Week Range $72.36

How does ARWR compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ARWR AAPG ABEO ABOS ABP

ARWR valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
10.9
▼ 15% below peers (12.9)
vs Peers
vs Industry
Fair value
P/B ratio
10.2
▲ 316% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ARWR profitability vs Biotechnology peers

ROE
-0.4%
▲ 99% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-0.2%
▲ 100% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-0.1%
▲ 100% above peers (-46.7%)
vs Peers
vs Industry
Top tier

ARWR financial health vs Biotechnology peers

D/E ratio
133.5
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
4.9
▲ 10% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.2
▲ 27% above peers (1.0)
vs Peers
vs Industry
More volatile

ARWR fundamentals radar

ARWR Peer median Industry

ARWR profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ARWR vs peers: key metrics

Latest News

Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma
Yahoo Finance · Mar 19